Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Sonic Healthcare Limited ( (AU:SHL) ).
Sonic Healthcare Limited announced a change in the director’s interest, specifically regarding Colin Stephen Goldschmidt’s holdings. The notice details the number of shares and options held by the director, including various unlisted options and performance rights with specific vesting periods and exercise prices. This change in director’s interest could impact the company’s governance and potentially influence investor perceptions.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.50 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, specializing in medical diagnostics and laboratory services. The company focuses on providing high-quality pathology and radiology services to a global market.
Average Trading Volume: 1,723,497
Technical Sentiment Signal: Sell
Current Market Cap: A$10.62B
For a thorough assessment of SHL stock, go to TipRanks’ Stock Analysis page.